INCIDENCE AND PREDICTORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEROCONVERSION IN PATIENTS ATTENDING SEXUALLY-TRANSMITTED DISEASE CLINICS IN INDIA

被引:107
作者
MEHENDALE, SM
RODRIGUES, JJ
BROOKMEYER, RS
GANGAKHEDKAR, RR
DIVEKAR, AD
GOKHALE, MR
RISBUD, AR
PARANJAPE, RS
SHEPHERD, ME
ROMPALO, AE
SULE, RR
TOLAT, SN
JADHAV, VD
QUINN, TC
BOLLINGER, RC
机构
[1] JOHNS HOPKINS UNIV,SCH MED,DIV INFECT DIS,BALTIMORE,MD 21205
[2] BJ MED COLL,NATL AIDS RES INST,POONA,MAHARASHTRA,INDIA
[3] DR KOTNIS MUNICIPAL DISPENSARY,POONA,MAHARASHTRA,INDIA
[4] NIAID,BETHESDA,MD 20892
关键词
D O I
10.1093/infdis/172.6.1486
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The first estimates of the seroincidence of human immunodeficiency virus type 1 (HIV-1) and of the risk factors for seroconversion in a cohort of high-risk patients attending sexually transmitted disease (STD) clinics in India are reported. Between 1993 and 1995, 851 HIV-1-seronegative persons were evaluated prospectively every 3 months for HIV infection and biologic and behavioral characteristics. The overall incidence of HIV-1 was 10.2/100 person-years (95% confidence interval, 7.9-13.1). The incidence among commercial sex workers (CSWs) was 26.1/100 person-years, compared with 8.4 among non-CSWs. Recurrent genital ulcer disease and urethritis or cervicitis during the follow-up period were independently associated with a 7- (P < .001) and 3-fold (P = .06) increased risk of HIV-1 seroconversion, respectively. Because of the association of recurrent ulcerative and nonulcerative STDs with HIV-1 seroconversion in this setting, behavioral and biologic measures directed at the prevention and control of STDs would be expected to greatly reduce the transmission of HIV-1 infection in similar high-risk groups.
引用
收藏
页码:1486 / 1491
页数:6
相关论文
共 21 条
  • [1] THE HUMAN-IMMUNODEFICIENCY-VIRUS EPIDEMIC IN INDIA - CURRENT MAGNITUDE AND FUTURE PROJECTIONS
    BOLLINGER, RC
    TRIPATHY, SP
    QUINN, TC
    [J]. MEDICINE, 1995, 74 (02) : 97 - 106
  • [2] BRESLOW NE, 1982, IAAC SCI PUBL, V2, P1
  • [3] BROOKMEYER R, 1995, IN PRESS AM J EPIDEM
  • [4] CAMERON DW, 1989, LANCET, V2, P403
  • [5] COX DR, 1972, J R STAT SOC B, V34, P187
  • [6] Cox DR, 1984, ANAL SURVIVAL DATA, pviii
  • [7] HASMUKH S, 1992, 8 INT C AIDS 3 STD W
  • [8] SEROCONVERSION IN PATIENTS ATTENDING SEXUALLY-TRANSMITTED DISEASE CLINICS
    KASSLER, WJ
    ZENILMAN, JM
    ERICKSON, B
    FOX, R
    PETERMAN, TA
    HOOK, EW
    [J]. AIDS, 1994, 8 (03) : 351 - 355
  • [9] ISOLATION OF HUMAN IMMUNODEFICIENCY VIRUS FROM GENITAL ULCERS IN NAIROBI PROSTITUTES
    KREISS, JK
    COOMBS, R
    PLUMMER, F
    HOLMES, KK
    NIKORA, B
    CAMERON, W
    NGUGI, E
    ACHOLA, JON
    COREY, L
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1989, 160 (03) : 380 - 384
  • [10] NON-ULCERATIVE SEXUALLY-TRANSMITTED DISEASES AS RISK-FACTORS FOR HIV-1 TRANSMISSION IN WOMEN - RESULTS FROM A COHORT STUDY
    LAGA, M
    MANOKA, A
    KIVUVU, M
    MALELE, B
    TULIZA, M
    NZILA, N
    GOEMAN, J
    BEHETS, F
    BATTER, V
    ALARY, M
    HEYWARD, WL
    RYDER, RW
    PIOT, P
    [J]. AIDS, 1993, 7 (01) : 95 - 102